Showing posts with label 2nd line therapy. Show all posts
Showing posts with label 2nd line therapy. Show all posts
Thursday, January 27, 2011
press release/media: For the Treatment of Second-Line Platinum Sensitive Advanced Ovarian Cancer, One-Third of Surveyed Oncologists Indicate That Paclitaxel/Carboplatin Has the Best Overall Clinical Profile When Compared to Other Currently Available Therapies
add your opinions
2nd line therapy
,
Carboplatin
,
second-line
,
Taxol
Subscribe to:
Posts
(
Atom
)